Price as a challenge to the sustainability of the universal access policy to antiretrovirals in SUS: the case of dolutegravir
{{output}}
The price of antiretrovirals (ARVs) continues to be a challenge to guarantee universal, comprehensive, and equitable pharmaceutical services. This article aimed to analyze the acquisition of the most widely used ARV in Brazil, comparing national and internatio... ...
